Waters, C. H., Nausieda, P., Dzyak, L., Spiegel, J., Rudzinska, M., Silver, D. E., . . . Gupta, S. (2015). Long-Term Treatment with Extended-Release Carbidopa–Levodopa (IPX066) in Early and Advanced Parkinson’s Disease: A 9-Month Open-Label Extension Trial. CNS Drugs.
استشهاد بنمط شيكاغوWaters, Cheryl H., et al. "Long-Term Treatment With Extended-Release Carbidopa–Levodopa (IPX066) in Early and Advanced Parkinson’s Disease: A 9-Month Open-Label Extension Trial." CNS Drugs 2015.
MLA استشهادWaters, Cheryl H., et al. "Long-Term Treatment With Extended-Release Carbidopa–Levodopa (IPX066) in Early and Advanced Parkinson’s Disease: A 9-Month Open-Label Extension Trial." CNS Drugs 2015.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.